Revolution Medicines, Inc. (RVMD) balance sheet
NASDAQ · Healthcare · Biotechnology · 883 employees · CEO Mark A. Goldsmith
- Price
- $191.31 +0.55%
- Market cap
- $41B
- Enterprise value
- $40.8B
- Last report
- Q2 '26 filed 2026-08-05
- Next report
- 2026-11-04 EPS est. -$2.35
At the end of Q2 '26 Revolution Medicines, Inc. (RVMD) held $3.94B in cash and short-term investments against $642M of debt incl. leases. Total assets $4.32B, total liabilities $1.72B, shareholders' equity $2.61B.
Balance sheet
| Balance sheet | Trend | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & equivalents | $358M | $696M | $288M | $276M | $201M | $543M | $334M | $402M | $217M | $384M | $441M | $815M | |
| Short-term investments | $455M | $1.16B | $1.42B | $1.32B | $1.35B | $1.75B | $1.77B | $1.73B | $1.71B | $1.64B | $1.47B | $3.12B | |
| Receivables | $309K | $1.25M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other current assets | $11M | $25.1M | $25.7M | $34M | $29.7M | $38.3M | $31.9M | $39.3M | $0 | $49.4M | $59.8M | $0 | |
| Current assets | $824M | $1.88B | $1.73B | $1.62B | $1.58B | $2.33B | $2.13B | $2.18B | $1.98B | $2.08B | $1.97B | $4.03B | |
| Property, plant & equipment (net) | $73.4M | $100M | $99.9M | $101M | $99.2M | $142M | $143M | $147M | $167M | $165M | $161M | $162M | |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $42.5M | |
| Goodwill | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | |
| Intangible assets | $58M | $57.7M | $57.5M | $57.2M | $56.9M | $56.7M | $56.4M | $56.1M | $55.9M | $55.8M | $55.8M | $55.8M | |
| Other non-current assets | $13.7M | $10.1M | $7.19M | $11.3M | $13.2M | $17.6M | $16.8M | $35.3M | $36.6M | $43.8M | $54M | $19.6M | |
| Non-current assets | $160M | $182M | $179M | $184M | $184M | $231M | $231M | $253M | $274M | $279M | $286M | $295M | |
| Total assets | $984M | $2.06B | $1.91B | $1.81B | $1.76B | $2.56B | $2.37B | $2.43B | $2.25B | $2.35B | $2.25B | $4.32B | |
| Liabilities | |||||||||||||
| Accounts payable | $29.6M | $61.8M | $32.4M | $29.3M | $24.5M | $54.4M | $47.5M | $56.8M | $74.8M | $64.6M | $80.5M | $88.4M | |
| Accrued expenses | $36.9M | $47.2M | $42.6M | $52.3M | $57.7M | $65.3M | $84M | $92.5M | $114M | $143M | $166M | $249M | |
| Other current liabilities | $13.3M | $27.5M | $10.5M | $15.4M | $20.4M | $31.4M | $14.1M | $22.2M | $40M | $66.1M | $26.5M | $0 | |
| Current liabilities | $85.5M | $144M | $93.7M | $105M | $111M | $164M | $159M | $185M | $246M | $290M | $290M | $354M | |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $142M | $281M | $487M | |
| Lease obligations (non-current) | $57.1M | $80.6M | $79.9M | $79.1M | $78.3M | $123M | $121M | $120M | $142M | $0 | $140M | $138M | |
| Deferred tax liabilities | $3.16M | $3.12M | $3.12M | $3.12M | $3.12M | $2.35M | $2.35M | $2.35M | $2.35M | $2.35M | $2.35M | $2.35M | |
| Other non-current liabilities | $982K | $7.97M | $6.2M | $2.06M | $4.41M | $3.86M | $4.89M | $258M | $265M | $288M | $41.2M | $735M | |
| Non-current liabilities | $61.2M | $91.7M | $89.2M | $84.3M | $85.8M | $129M | $129M | $380M | $409M | $433M | $464M | $1.36B | |
| Total liabilities | $147M | $236M | $183M | $190M | $197M | $293M | $287M | $564M | $655M | $723M | $754M | $1.72B | |
| Equity | |||||||||||||
| Common stock & paid-in capital | $11K | $16K | $16K | $16K | $16K | $18K | $18K | $18K | $18K | $19K | $19K | $21K | |
| Retained earnings | -$976M | -$1.14B | -$1.25B | -$1.39B | -$1.54B | -$1.74B | -$1.95B | -$2.2B | -$2.5B | -$2.87B | -$3.32B | -$3.97B | |
| Accumulated other comprehensive income | -$871K | $544K | -$1.2M | -$1.86M | $3.81M | $1.32M | $1.71M | $1.3M | $3.12M | $3.24M | -$622K | -$5.95M | |
| Shareholders' equity | $837M | $1.83B | $1.73B | $1.62B | $1.57B | $2.27B | $2.08B | $1.87B | $1.6B | $1.63B | $1.5B | $2.61B | |
| Debt | |||||||||||||
| Total debt (incl. leases) | $62.8M | $87.9M | $88M | $87.4M | $86.7M | $136M | $134M | $133M | $158M | $159M | $437M | $642M | |
| Net debt (debt - cash) | -$296M | -$608M | -$200M | -$188M | -$115M | -$407M | -$199M | -$270M | -$59M | -$225M | -$3.67M | -$174M | |
| Balance sheet | Trend | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & equivalents | $9.08M | $69.6M | $16.7M | $104M | $108M | $161M | $696M | $543M | $384M | |
| Short-term investments | $0 | $0 | $106M | $336M | $469M | $484M | $1.16B | $1.75B | $1.64B | |
| Receivables | $0 | $7.3M | $8.74M | $6.39M | $5.93M | $4.67M | $1.25M | $0 | $0 | |
| Inventory | $0 | $6.6M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other current assets | $0 | $6.6M | $0 | $0 | $0 | $10.6M | $25.1M | $38.3M | $49.4M | |
| Current assets | $9.44M | $85.4M | $134M | $454M | $590M | $660M | $1.88B | $2.33B | $2.08B | |
| Property, plant & equipment (net) | $5.25M | $6.87M | $7.15M | $36.3M | $71.2M | $73.7M | $100M | $142M | $165M | |
| Goodwill | $0 | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | $14.6M | |
| Intangible assets | $0 | $63.1M | $62M | $60.9M | $59.9M | $58.8M | $57.7M | $56.7M | $55.8M | |
| Other non-current assets | $383K | $593K | $2.78M | $1.39M | $2.5M | $4.59M | $10.1M | $17.6M | $43.8M | |
| Non-current assets | $5.64M | $85.2M | $86.5M | $113M | $148M | $152M | $182M | $231M | $279M | |
| Total assets | $15.1M | $171M | $221M | $567M | $738M | $812M | $2.06B | $2.56B | $2.35B | |
| Liabilities | ||||||||||
| Accounts payable | $3.35M | $5.24M | $11.4M | $12.6M | $14.1M | $21.3M | $61.8M | $54.4M | $64.6M | |
| Accrued expenses | $1.7M | $2.28M | $8.8M | $11M | $17.6M | $15.7M | $47.2M | $65.3M | $143M | |
| Deferred revenue | $0 | $16.8M | $17.1M | $12.1M | $12.4M | $4.46M | $0 | $0 | $0 | |
| Other current liabilities | $2.55M | $6.06M | $5.73M | $7.83M | $10.2M | $13.8M | $27.5M | $31.4M | $66.1M | |
| Current liabilities | $7.6M | $30.6M | $43.1M | $47.2M | $60.4M | $62M | $144M | $164M | $290M | |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $142M | |
| Lease obligations (non-current) | $0 | $0 | $0 | $29M | $60.4M | $57.4M | $80.6M | $123M | $0 | |
| Deferred revenue (non-current) | $0 | $28.4M | $14.7M | $8.48M | $6.57M | $0 | $0 | $0 | $0 | |
| Deferred tax liabilities | $0 | $12.2M | $7.82M | $7.44M | $7.44M | $7.03M | $3.12M | $2.35M | $2.35M | |
| Other non-current liabilities | $2.95M | $2.77M | $2.4M | $632K | $634K | $301K | $7.97M | $3.86M | $288M | |
| Non-current liabilities | $2.95M | $43.4M | $24.9M | $45.5M | $75.1M | $64.8M | $91.7M | $129M | $433M | |
| Total liabilities | $10.5M | $73.9M | $68M | $92.7M | $135M | $127M | $236M | $293M | $723M | |
| Equity | ||||||||||
| Common stock & paid-in capital | $0 | $0 | $0 | $7K | $8K | $9K | $16K | $18K | $19K | |
| Retained earnings | -$67.9M | -$110M | -$157M | -$266M | -$453M | -$701M | -$1.14B | -$1.74B | -$2.87B | |
| Accumulated other comprehensive income | $0 | $0 | $74K | $116K | -$376K | -$1.78M | $544K | $1.32M | $3.24M | |
| Shareholders' equity | $4.53M | $96.7M | $153M | $475M | $603M | $685M | $1.83B | $2.27B | $1.63B | |
| Debt | ||||||||||
| Total debt (incl. leases) | $0 | $147K | $0 | $32.7M | $66.6M | $64.2M | $87.9M | $136M | $159M | |
| Net debt (debt - cash) | -$9.08M | -$69.4M | -$16.7M | -$71.6M | -$41.9M | -$97.2M | -$608M | -$407M | -$225M | |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Cash, investments and debt
quarter endsThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-02